You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.īy using this site, you agree to the Terms of Service and Privacy Policy. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. in error matrixes (see tables A-G on following pages) are all coming from. All timestamps are reflected in IST (Indian Standard Time).ĭISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. 2 Knots of Lupinus means here, an island of Lupinus inside another kind of. Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. (for corporate data, historical price & volume, F&O data). As on 31-03-2023, the company has a total of 45.50 Crore shares outstanding.ĭATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. The company’s top management includes Mrs.Manju D Gupta, Dr.Kamal K Sharma, Mr.Nilesh D Gupta, Ms.Vinita Gupta, Mr.Ramesh Swaminathan, Ms.Christine Mundkur, Mr.Jean-Luc Belingard, Mr.K B S Anand, Mr.Mark D McDade, Dr.Punita Kumar-Sinha, Mr.R V Satam.

Company has reported net profit after tax of Rs 242.39 Crore in latest quarter. For the quarter ended 31-03-2023, the company has reported a Consolidated Total Income of Rs 4,467.35 Crore, up 2.93 % from last quarter Total Income of Rs 4,340.18 Crore and up 14.59 % from last year same quarter Total Income of Rs 3,898.71 Crore. key Products/Revenue Segments include Pharmaceuticals, Other Services, Other Operating Revenue and Export Incentives for the year ending 3. Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 35,977.65 Crore) operating in Pharmaceuticals sector.

The Second Coming by Lupinus